Key result
Large-calibre (≥18 mm) ePTFE-valved conduits for right ventricular outflow tract reconstruction showed excellent durability, with 96.6% overall survival and 89.0% freedom from explantation at 10 years.
Why the study?
Handmade ePTFE-valved conduits are widely used in Japan for RVOT reconstruction due to limited homograft and bovine jugular vein availability, but their long-term outcomes and durability needed clarification independently of somatic growth.
Do large-calibre ePTFE-valved conduits provide durable long-term outcomes in patients undergoing right ventricular outflow tract reconstruction?
Cohort (n=502)
Yes
Do large-calibre ePTFE-valved conduits provide durable long-term outcomes in patients undergoing right ventricular outflow tract reconstruction?
Large-calibre ePTFE-valved conduits with bulging sinuses demonstrate excellent long-term survival and freedom from explantation up to 10 years for right ventricular outflow tract reconstruction.
Answers are grounded in this paper and cite their sources.
Supports durability of handmade ePTFE-valved conduits for large RVOT reconstructions; leaves open need for prospective comparisons with homografts.
OBJECTIVES: In Japan, homograft and bovine jugular vein are available in very limited institutions for the reconstruction of the right ventricular outflow tract, and handmade expanded polytetrafluoroethylene (ePTFE)-valved conduits have been widely used instead. This study aimed to clarify the long-term outcomes and the durability of the ePTFE-valved conduits purely by narrowing down to those with large sizes to eliminate the influence of the body growth. METHODS: Between January 2002 and December 2015, patients who underwent right ventricular outflow tract reconstruction in 34 Japanese institutions using ePTFE-valved conduits with a diameter of ≥18 mm were included. All the valved conduits were made in the authors' institution and delivered to each participating institution. RESULTS: Overall, 502 patients were included. Early mortality was 1.4% and not related to conduit failure. The overall survival rate was 98.2% at 5 years and 96.6% at 10 years. Freedom from conduit explantation was 99.5% at 5 years and 89.0% at 10 years. Three patients (0.13 per 100 patient-years) developed infective endocarditis of the conduit, and only 1 patient required conduit removal. Pulmonary insufficiency was mild or less in 480 (96%) patients, and conduit stenosis was mild or less in 436 (88%) patients at the latest follow-up. CONCLUSIONS: By narrowing the analyses down to only ePTFE conduits with a large size, satisfactory long-term outcomes of these conduits with a fan-shaped valve and bulging sinuses were shown. These conduits would be among the optimal choices for right ventricular outflow tract reconstruction.
No takes yet. Share an insight, caveat, or question.
Fujita et al. (2020) conducted a cohort in Right ventricular outflow tract reconstruction (n=502). Large-calibre (≥18 mm) ePTFE-valved conduits was evaluated on Overall survival rate at 10 years. Large-calibre (≥18 mm) ePTFE-valved conduits for right ventricular outflow tract reconstruction showed excellent durability, with 96.6% overall survival and 89.0% freedom from explantation at 10 years.
Synapse has enriched 10 related papers. Consider them for comparative context: